Sanctions Compliance in Biotech Trade

Introduction

Sanctions compliance in biotechnology trade refers to the legal obligation of companies, research institutions, exporters, importers, and financial intermediaries to ensure that their transactions do not violate economic sanctions, trade restrictions, or export-control laws. Biotechnology trade may involve vaccines, diagnostic kits, laboratory equipment, genetic-testing technologies, biological materials, research software, and technical knowledge.

Sanctions are generally imposed to protect national security, prevent the proliferation of weapons, respond to international conflicts, or restrict dealings with designated persons and entities. Non-compliance can result in civil penalties, criminal prosecution, denial of export privileges, confiscation of goods, and reputational damage.

The subject is governed by several overlapping legal regimes. In India, relevant laws include the Foreign Trade (Development and Regulation) Act, 1992, the Foreign Trade Policy, the Customs Act, 1962, and the Weapons of Mass Destruction and their Delivery Systems (Prohibition of Unlawful Activities) Act, 2005. International transactions may also be affected by United Nations sanctions and the sanctions or export-control laws of countries such as the United States and members of the European Union.

Important Case Laws and Enforcement Decisions

*1. Indiana University — BIS Settlement (2024)

The U.S. Bureau of Industry and Security settled alleged export-control violations involving 42 exports of genetically modified fruit flies that produced a controlled toxin subunit. The university had exported them to research institutions without required licences. Voluntary disclosure, cooperation, and corrective measures were considered in resolving the matter. This illustrates that academic and research institutions are also subject to export-control duties.

Bureau of Industry and Security

*2. Luminultra — U.S. Commerce Department Enforcement (2025)

A Canadian biotechnology company was reported to have exported U.S.-origin water-testing equipment and test kits to Iran through the UAE, while falsifying declarations. The matter demonstrates how diversion through a third country and false shipping information can create sanctions and export-control exposure. It is an enforcement action, not a judicial precedent.

Institute For Science And International Security

*3. Applied Materials — BIS Enforcement (2026)

The BIS imposed a $252 million penalty in a case involving unlicensed exports of controlled semiconductor manufacturing equipment routed through a third country to a restricted Chinese entity. Though not a biotechnology case, it illustrates the legal risk of indirect shipment and the importance of examining the ultimate recipient, not merely the immediate buyer.

Bureau of Industry and Security

These examples are administrative enforcement decisions rather than Indian court judgments. A directly on-point Indian reported judicial precedent specifically concerning biotechnology sanctions violations is not readily identifiable; Indian compliance is therefore primarily explained through the statutory framework and export-control practice.

Compliance Obligations and Liability

Biotechnology businesses should adopt a risk-based compliance programme that includes:

Product classification: Determine whether biological materials, equipment, software, or technical information fall within SCOMET or another export-control list.

Party screening: Screen buyers, distributors, research partners, banks, and end users against applicable sanctions lists.

End-use verification: Obtain credible end-use and end-user statements and assess diversion risks.

Licensing: Obtain the required DGFT authorisation before exporting controlled items. SCOMET exports generally require authorisation unless specifically exempted.

Mumbai Customs Zone – III+1

Recordkeeping and monitoring: Maintain transaction documents, licences, shipping records, and compliance reviews.

Training and internal controls: Ensure employees recognise red flags, including unusual routing, opaque intermediaries, and requests to falsify export documents.

Under Indian law, the FTDR Act and Foreign Trade Policy regulate restricted exports, while the WMD Act addresses prohibited dealings connected with weapons of mass destruction and related proliferation risks. India also implements applicable UN Security Council sanctions through domestic legal instruments.

Ministry of External Affairs+1

Conclusion

Sanctions compliance in biotechnology trade is essential to prevent sensitive biological materials, technologies, and equipment from reaching prohibited end users or being diverted to unlawful purposes. Indian exporters must comply with SCOMET licensing, customs, foreign-trade, and applicable UN sanctions requirements. International sanctions may also apply where a transaction has a relevant connection to another jurisdiction, such as U.S.-origin goods or U.S.-regulated technology.

The enforcement examples involving Indiana University and Luminultra demonstrate that both research institutions and commercial biotechnology businesses may face serious consequences for unauthorised exports or deceptive routing. Effective compliance requires accurate classification, screening, licensing, end-use verification, and transparent documentation.